Complications of radical surgery for advanced ovarian cancer;Complications de la chirurgie radicale des cancers de l'ovaire de stade avancé

Gynecologie Obstetrique et Fertilite

Volumn 39, Issue 1, 2011, Pages 21-27

  Chereau E ^a   Ballester, M ^a   Lesieur, B ^a   Selle, F ^a   Coutant, C ^a   Rouzier, R ^a   Darai E ^a  

^a HÔPITAL TENON   (France)

Author keywords

Advanced ovarian cancer; Complete surgery; Morbidity; Radical surgery; Survival

Indexed keywords

CASE REPORT; CHOLECYSTECTOMY; CYSTIC LYMPHANGIOMA; HUMAN; LIVER METASTASIS; MORBIDITY; OVARY CANCER; REVIEW; SURGICAL MORTALITY;

EID: 79151469678     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2010.08.017     Document Type: Article

References (61)

1. S.M. Eisenkop, N.M. Spirtos, and W.C. Lin "Optimal" cytoreduction for advanced epithelial ovarian cancer: a commentary Gynecol Oncol 103 1 2006 329 335
2. D.S. Chi, E.L. Eisenhauer, J. Lang, J. Huh, L. Haddad, and N.R. Abu-Rustum What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103 2 2006 559 564
3. G.D. Aletti, S.C. Dowdy, B.S. Gostout, M.B. Jones, C.R. Stanhope, and T.O. Wilson Aggressive surgical effort and improved survival in advanced-stage ovarian cancer Obstet Gynecol 107 1 2006 77 85
4. S. Tangjitgamol, S. Manusirivithaya, M. Laopaiboon, and P. Lumbiganon Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review Gynecol Oncol 112 1 2009 257 264
5. Vergote I. Randomised trial comparing primary debulking surgery with neoadjuvant chemotherapy followed by interval debulking in stage IIIc-IV ovarian, fallopian tube and peritoneal cancer. IGCS meeting Bangkok 2008.
6. R.E. Bristow, R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 2002 1248 1259
7. S.M. Eisenkop, R.L. Friedman, and H.J. Wang Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study Gynecol Oncol 69 2 1998 103 108
8. R.E. Bristow, I. Puri, and D.S. Chi Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis Gynecol Oncol 112 1 2009 265 274
9. D.S. Chi, E.S. Venkatraman, V. Masson, and W.J. Hoskins The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma Gynecol Oncol 77 2 2000 227 231
10. D.S. Chi, O. Zivanovic, M.J. Palayekar, E.L. Eisenhauer, N.R. Abu-Rustum, and Y. Sonoda A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma Gynecol Oncol 112 1 2009 6 10
11. E.L. Eisenhauer, N.R. Abu-Rustum, Y. Sonoda, D.A. Levine, E.A. Poynor, and C. Aghajanian The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer Gynecol Oncol 103 3 2006 1083 1090
12. O. Zivanovic, E.L. Eisenhauer, Q. Zhou, A. Iasonos, P. Sabbatini, and Y. Sonoda The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer Gynecol Oncol 108 2 2008 287 292
13. G.D. Aletti, S.C. Dowdy, K.C. Podratz, and W.A. Cliby Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer Gynecol Oncol 100 2 2006 283 287
14. S.M. Kehoe, E.L. Eisenhauer, and D.S. Chi Upper abdominal surgical procedures: liver mobilization and diaphragm peritonectomy/resection, splenectomy, and distal pancreatectomy Gynecol Oncol 111 Suppl. 2 2008 S51 S55
15. P.E. Colombo, A. Mourregot, M. Fabbro, M. Gutowski, B. Saint-Aubert, and F. Quenet Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients Eur J Surg Oncol 35 2 2009 135 143
16. Chi DS, Eisenhauer E, Zivanovic O, Sonoda Y, Abu-Rustum N, Levine DA, at al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol 2009:114;26-31.
17. Chi DS, Franklin CC, Levine DA, Akselrod F, Sabbatini P, Jarnagin WR, et al. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol 2004:94;650-54.
18. P. Matthiessen, O. Hallbook, M. Andersson, J. Rutegard, and R. Sjodahl Risk factors for anastomotic leakage after anterior resection of the rectum Colorectal Dis 6 2004 462 469
19. C.S. McArdle, D.C. McMillan, and D.J. Hole Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer Br J Surg 92 2005 1150 1154
20. N.Y. Wong, and K.W. Eu A defunctioning ileostomy does not prevent clinical anastomotic leak after a low anterior resection: a prospective, comparative study Dis Colon Rectum 48 2005 2076 2079
21. D.L. Richardson, A. Mariani, and W.A. Cliby Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer Gynecol Oncol 103 2 2006 667 672
22. A. Obermair, S. Hagenauer, D. Tamandl, R.D. Clayton, J.L. Nicklin, and L.C. Perrin Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer Gynecol Oncol 83 1 2001 115 120
23. K.F. Tamussino, P.C. Lim, M.J. Webb, R.A. Lee, and T.G. Lesnick Gastrointestinal surgery in patients with ovarian cancer Gynecol Oncol 80 1 2001 79 84
24. G. Houvenaeghel, M. Gutowski, M. Buttarelli, J. Cuisenier, F. Narducci, and C. Dalle Modified posterior pelvic exenteration for ovarian cancer Int J Gynecol Cancer 19 5 2009 968 973
25. N. Gillette-Cloven, R.A. Burger, B.J. Monk, D.S. McMeekin, S. Vasilev, and P.J. DiSaia Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer J Am Coll Surg 193 6 2001 626 632
26. E. Chéreau, D. Stefanescu, F. Selle, R. Rouzier, and E. Daraï Spontaneous rectovaginal fistula during bevacizumab therapy for ovarian cancer: a case report Am J Obstet Gynecol 200 1 2009 e15 e16
27. P. Benedetti-Panici, F. Maneschi, G. Cutillo, G. D'Andrea, V.S. di Palumbo, and M. Conte A randomized study comparing retroperitoneal drainage with no drainage after lymphadenectomy in gynecologic malignancies Gynecol Oncol 65 3 1997 478 482
28. P. Morice, N. Lassau, P. Pautier, C. Haie-Meder, C. Lhomme, and D. Castaigne Retroperitoneal drainage after complete para-aortic lymphadenectomy for gynecologic cancer: a randomized trial Obstet Gynecol 97 2 2001 243 247
29. O.M. Bacha, M. Plante, L.S. Kirschnick, and M.I. Edelweiss Evaluation of morbidity of suction drains after retroperitoneal lyphadenectomy in gynecological tumors: a systematic literature review Int J Gynecol Cancer 19 2 2009 202 207
30. H.S. Scholz, E. Petru, C. Benedicic, J. Haas, K. Tamussino, and R. Winter Fibrin application for preventing lymphocysts after retroperitonal lymphadenectomy in patients with gynecologic malignancies Gynecol Oncol 84 2002 43 46
31. Rafii A, Camicas A, Ferron G, Mery E, Gladieff L, Delannes M, et al. A comparative study of laparoscopic extraperitoneal laparoscopy with the use of ultrasonically activated shears. Am J Obstet Gynecol 2009;201(4):370.e1-5.
32. K. Magri, V. Bertrand, J. Sautire, -L, X. Pivot, and D. Riethmuller Cost effectiveness of Ligasure Precise® versus surgical clips during axillary nodal dissection for breast cancer J Gynecol Obstet Biol Reprod (Paris) 35 2006 341 347
33. M. Kapella, J. Gana, E. Decroisette, and Y. Aubard Para-aortic lymphocele treated with an injection of somatostatine analog (lanreotide) Eur J Obstet Gynecol Reprod Biol 2008 doi:10.1016/j.ejogrb.2008.06.005
34. E Chéreau, M. Ballester, F. Selle, A. Cortez, C. Pomel, and E. Darai Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer BJOG 116 8 2009 1062 1068
35. E.L. Eisenhauer, M.I. D'Angelica, N.R. Abu-Rustum, Y. Sonoda, W.R. Jarnagin, and R.R. Barakat Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer Gynecol Oncol 103 3 2006 871 877
36. Bertin ML, Crowe J, Gordon SM. Determinants of surgical site infection after breast surgery. Am J Infect Control 1998;26(5):522-52.
37. C.G. Gerestein, R.A. Damhuis, C.W. Burger, and G.S. Kooi Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review Gynecol Oncol 114 3 2009 523 527
38. Gerestein CG, Damhuis RA, de Vries M, Reedijk A, Burger CW, Kooi GS. Causes of postoperative mortality after surgery for ovarian cancer. Eur J Cancer 2009;45(16):2799-803.
39. W. Cliby, S. Dowdy, S.S. Feitoza, B.S. Gostout, and K.C. Podratz Diaphragm resection for ovarian cancer: technique and short-term complications Gynecol Oncol 94 3 2004 655 660
40. S.M. Mourton, L.K. Temple, N.R. Abu-Rustum, M.L. Gemignani, Y. Sonoda, and B.H. Bochner Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer Gynecol Oncol 99 3 2005 608 614
41. S.C. Dowdy, R.T. Loewen, G. Aletti, S.S. Feitoza, and W. Cliby Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma Gynecol Oncol 109 2 2008 303 307
42. G. Deppe, V.K. Malviya, G. Boike, and A. Hampton Surgical approach to diaphragmatic metastases from ovarian cancer Gynecol Oncol 24 2 1986 258 260
43. F.J. Montz, J.B. Schlaerth, and J.S. Berek Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer Gynecol Oncol 35 3 1989 338 340
44. S.J. Kapnick, C.T. Griffiths, and N.J. Finkler Occult pleural involvement in stage III ovarian carcinoma: role of diaphragm resection Gynecol Oncol 39 2 1990 135 138
45. E. Petru, K. Tamussino, M. Lahousen, R. Winter, H. Pickel, and J. Haas Pelvic and paraaortic lymphocysts after radical surgery because of cervical and ovarian cancer Am J Obstet Gynecol 161 4 1989 937 941
46. J.M. Estes, C.A. Leath 3rd., J.M. Straughn Jr., R.P. Rocconi, T.O. Kirby, and W.K. Huh Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy J Am Coll Surg 203 4 2006 527 532
47. K. Devolder, F. Amant, P. Neven, T. van Gorp, K. Leunen, and I. Vergote Role of diaphragmatic surgery in 69 patients with ovarian carcinoma Int J Gynecol Cancer 18 2 2008 363 368
48. G.D. Aletti, A. Santillan, E.L. Eisenhauer, J. Hu, G. Aletti, and K.C. Podratz A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model Gynecol Oncol 107 1 2007 99 106
49. I. Zighelboim, N. Kizer, N.P. Taylor, A.S. Case, F. Gao, and P.H. Thaker Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian cancer Gynecol Oncol 116 3 2010 370 373
50. Vergote I, et al. Randomised trial comparing primary debulking surgery with neoadjuvant chemotherapy, followed by interval debulking in stage IIIc-IV ovarian, fallopian tube and peritoneal cancer. IGCS Bangkok, 2008.
51. Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P. Interval debulking surgery for advanced epithelial ovarian cancer. Cochrane Database Syst Rev 2009;2 [CD006014].
52. R.E. Bristow, and D.S. Chi Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis Gynecol Oncol 103 3 2006 1070 1076
53. R.E. Bristow, M.L. Zahurak, T.P. Diaz-Montes, R.L. Giuntoli, and D.K. Armstrong Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes Gynecol Oncol 115 3 2009 334 338
54. D. Querleu, and F. Narducci Quality control criteria in the surgical management of advanced ovarian cancers Bull Cancer 96 12 2009 1255 1262
55. M.R. Arain, and D.J. Buggy Anaesthesia for cancer patients Curr Opin Anaesthesiol 20 2007 247 253
56. L. Minig, R. Biffi, V. Zanagnolo, A. Attanasio, C. Beltrami, and L. Bocciolone Reduction of postoperative complication rate with the use of early oral feeding in gynecologic oncologic patients undergoing a major surgery: a randomized controlled trial Ann Surg Oncol 16 11 2009 3101 3110
57. Charoenkwan K, Phillipson G, Vutyavanich T. Early versus delayed (traditional) oral fluids and food for reducing complications after major abdominal gynaecologic surgery. Cochrane Database Syst Rev 2007;4 [CD004508].
58. H.P. Van't Sant, W.F. Weidema, W.C. Hop, H.J. Oostvogel, and C.M. Contant The influence of mechanical bowel preparation in elective lower colorectal surgery Ann Surg 251 1 2010 59 63
59. A. Gadducci, S. Cosio, N. Spirito, and A.R. Genazzani The perioperative management of patients with gynaecological cancer undergoing major surgery: a debated clinical challenge Crit Rev Oncol Hematol 73 2 2010 126 140
60. D. Tsolakidis, F. Amant, T. Van Gorp, K. Leunen, P. Neven, and I. Vergote Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer Gynecol Oncol 116 3 2010 489 496
61. F. Fanfani, A. Fagotti, V. Gallotta, A. Ercoli, F. Pacelli, and B. Costantini Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery Gynecol Oncol 116 3 2010 497 501